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Abstract
Background The aim of this study was to validate in a 10-year follow-up the initial outcomes of various thyroid
resection methods for multinodular non-toxic goiter (MNG) reported in World J Surg 2010;34:1203–13.
Materials and methods Six hundred consenting patients with MNG were randomized to three groups of 200 patients
each: total thyroidectomy (TT), Dunhill operation (DO), bilateral subtotal thyroidectomy (BST). Obligatory follow-
up period of 60 months was extended up to 120 months for all the consenting patients. The primary outcome measure
was the prevalence of recurrent goiter and need for revision thyroid surgery. The secondary outcome measure was the
cumulative postoperative and post-revision morbidity rate.
Results The primary outcomes were twice as inferior at 10 years when compared to 5-year results for DO and BST, but
not for TT. Recurrent goiter was found at 10 years in 1 (0.6%) TT versus 15 (8.6%) DO versus 39 (22.4%) BST
(p\ 0.001), and revision thyroidectomy was necessary in 1 (0.6%) TT versus 5 (2.8%) DO versus 14 (8.0%) BST
patients (p\ 0.001). Any permanent morbidity at 10 years was present in 5 (2.8%) TT patients following initial surgery
versus 7 (4.0%) DO and 10 (5.7%) BST patients following initial and revision thyroidectomy (nonsignificant differ-
ences). At 10 years, 23 (11.5%) TT versus 25 (12.5%) DO versus 26 (13.0%) BST patients were lost to follow-up.
Conclusions Total thyroidectomy can be considered the preferred surgical approach for patients with MNG, as it
abolishes the risk of goiter recurrence and need for future revision thyroidectomy when compared to more limited
thyroid resections, whereas the prevalence of permanent morbidity is not increased at experienced hands.
Registration number: NCT00946894 (http://www.clinicaltrials.gov).
Introduction
In recent years, total thyroidectomy has become increas-
ingly popular in the treatment of bilateral multinodular
non-toxic goiter (MNG), replacing subtotal thyroidectomy
in many high-volume endocrine surgery units worldwide
[1, 2]. Nevertheless, the major benefits of total thyroidec-
tomy understood as the risk of recurrent goiter reduced to
almost zero and abolished need for revision thyroid surgery
in the future should be balanced against the risk of post-
operative morbidity. Thus, total thyroidectomy for benign
thyroid disease continues to remain controversial, as there
are many conflicting data published in the literature
regarding the risk of hypoparathyroidism and recurrent
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laryngeal nerve injury stratified to indications for surgery,
extent of thyroid resection and surgical volume [2–5].
Cirocchi et al. [6] published recently a Cochrane system-
atic review focused on total and near-total thyroidectomy
versus subtotal thyroidectomy for MNG in adults and
identified only four randomized controlled trials (RCT) in
the field. Despite the fact that goiter recurrence was found
to be reduced following total thyroidectomy (TT), the
effects on other major endpoints, such as the need for
revision surgery for goiter recurrence, prevalence of
adverse events, and thyroid cancer incidence, remained
unclear. Hence, new RCTs with a long-term follow-up and
with additional focus on data such as surgical experience,
surgical volume, and more attention to surgical technique
were found to be needed [6]. To fulfill this gap in evidence
with more data, it was decided at our institution to continue
follow-up of all consenting patients previously included
into RCT for 5 years [7]. Thus, the aim of this study was to
validate in a 10-year follow-up the outcomes of RCT run at
our institution and published in 2010 comparing results of
various thyroid resection modes hitherto assessed within
5 years following surgery [7]. The hypothesis explored at
the present study was that the prevalence of recurrent goiter
and need for revision thyroidectomy would increase with
time of follow-up and that the cumulative risk of postop-
erative and post-revision morbidity of more limited thyroid
resection modes would overweight the initial risk of total
thyroidectomy.
Materials and methods
Study design and patient selection
Patients referred to the Department of Endocrine Surgery,
Third Department of General Surgery, Jagiellonian
University Medical College in Krakow, for first-time thy-
roid surgery between January 2000 and December 2003
were registered. Eligible patients with MNG were assessed
for the study. The study was approved by the institutional
review board.
The inclusion criterion was a bilateral non-toxic MNG
with the posterior aspects of both thyroid lobes appearing
normal on ultrasound of the neck.
The exclusion criteria included: MNG involving the
posterior aspect/s of thyroid lobe/s, suspicion of thyroid
cancer, previous thyroid surgery, thyroiditis, subclinical or
clinically overt hypothyroidism or hyperthyroidism, preg-
nancy or lactation, age\ 18 years or[ 65 years, ASA 4
grade (American Society of Anesthesiology), and inability
to comply with the follow-up protocol.
Patients who signed the informed consent were ran-
domized to three groups: total thyroidectomy (TT), Dunhill
operation (DO), and bilateral subtotal thyroidectomy
(BST).
The primary outcome measure was the prevalence of
recurrent goiter and need for redo surgery. The secondary
outcome measure was the cumulative postoperative and
post-revision morbidity rate (hypoparathyroidism and
recurrent laryngeal nerve injury).
Randomization
The randomization sequence was generated by a computer.
Sequencing was based on permuted blocks of two and three
to balance the number of patients in the treatment groups.
The patients were allocated randomly to one of the three
treatment groups in a 1:1:1 ratio. Information on the type of
intervention remained in consecutively numbered and
sealed envelopes that were stored in the operating theater.
An envelope containing the allocation was added to the
patient’s file in the operating room. The envelope was
opened, and the surgeon performed the assigned interven-
tion. All the participants were blinded to treatment
assignment for the duration of the study.
Anesthesia
Operations in both groups were performed under general
anesthesia. Two anesthesiologists involved in the study
followed a strict protocol including premedication with IV
midazolam and anesthesia induction with fentanyl,
thiopental, and pancuronium at the body mass-dependent
dose. After the endotracheal intubation, all the patients
were put on mechanical ventilation (sevoflurane and oxy-
gen mixture).
Surgical technique
All the operations were performed by one of the three
experienced endocrine surgeons involved in the study.
Each of them performed approximately one-third of the
operations in each study arm. In the TT group, the opera-
tion consisted of extracapsular total thyroidectomy, and in
the DO group, the operation consisted of unilateral extra-
capsular total thyroidectomy and contralateral subtotal
thyroid lobe resection (leaving a thyroid stump of
approximately 2 g of normal remnant tissue), whereas in
the ST group, the operation consisted of bilateral subtotal
thyroidectomy (leaving thyroid stumps of approximately
2 g of normal remnant tissue each on both sides of the
neck). In each group, efforts were made to identify and
remove the entire pyramidal thyroid lobe. In each patient,
the recurrent laryngeal nerves were exposed and the
branches of the superior and inferior thyroid arteries were
divided close to the thyroid capsule (peripheral ligation).
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Intraoperative nerve monitoring (IONM) was not used for
initial surgery in this study. However, IONM was utilized
for 15 of 20 (75%) revision operations for recurrent goiter
in this study, depending on individual surgical preferences.
A lateral approach was routinely used for all reoperative
cases. The surgical technique of reoperation for recurrent
goiter was described in detail in our previous publication
[8]. The parathyroid glands were meticulously dissected
from the thyroid gland, and effort was made to identify all
the four parathyroid glands and preserve as many as pos-
sible ‘‘in situ.’’ Any inadvertently removed parathyroid
gland found on inspection to be lying on the thyroid cap-
sule, any gland that was anatomically impossible to be
preserved, as well as any devascularized gland were elec-
tively reimplanted into the sternocleidomastoid muscle
using the standard technique of parathyroid autotrans-
plantation as described by Wells et al. [9].
Preoperative evaluation and postoperative follow-up
High-resolution Doppler ultrasound of the neck with both
7.5- and 12-MHz linear array transducers (Logiq 7; GE,
Solingen, Germany) was performed during an outpatient
visit prior to admission by a single endocrine surgeon (MB)
experienced in thyroid ultrasound imaging. Thyroid vol-
umes were calculated according to the spherical ellipsoid
formula: volume = p/6 9 anteroposterior diameter
(cm) 9 width (cm) 9 length (cm). Fine-needle aspiration
(FNA) was performed in all the patients prior to enroll-
ment. Preoperative evaluation included serum free T3, free
T4, thyroid-stimulating hormone (TSH) concentrations
(respectively by commercial radioimmunoassay kits and
ultrasensitive method) and serum thyroid peroxidase anti-
bodies (TPOAb) levels.
All the patients underwent ultrasonographic, cytologi-
cal, and biochemical follow-up for 60 months postopera-
tively. However, for all the consenting patients, the follow-
up period was extended to 120 months postoperatively. All
the patients were evaluated at 3, 6, 9, and 12 months
postoperatively during the first year, and every 12 months
for the following years. Biochemical evaluation consisted
of determining serum TSH concentrations. Thyroid ultra-
sonography was performed by the same operator (MB)
using the same equipment as in preoperative evaluation
(Logiq 7; GE, Solingen, Germany). All the patients in this
study, irrespectively of the individual group assignment,
received postoperative levothyroxine treatment. The
levothyroxine dose was adjusted to serum TSH concen-
trations to keep it within the lowest two-thirds of the ref-
erence range (0.3–2.5 mU/L). This therapeutic strategy
was focused on avoiding the risk of mild thyrotoxicosis and
limiting the excessive TSH stimulation of the thyroid
remnants (in the DO and BST groups).
The following criteria were used to define recurrence of
nodular lesions within the remnant thyroid tissue (the same
as previously reported in the Miccoli study): presence of
hypoechoic or hyperechoic nodular pattern at least 5 mm in
diameter, identification of perinodular hypoechogenic or
hyperechogenic halo, and presence of an anechoic lesion
with a reinforced posterior wall [10]. FNA was electively
performed during the follow-up period in all the cases of
identified thyroid lesions larger than 1 cm in diameter
within the remnant thyroid tissue. The following indica-
tions for reoperation were used: presence of a 3 cm, or
larger nodule, result of FNA suggestive of an increased risk
for malignancy, and presence of compressive symptoms.
Indirect laryngoscopy by an ENT specialist was mandatory
before surgery and before discharge. In patients with RLN
paresis, an additional examination was scheduled at
2 weeks and 1, 2, 4, 6, and 12 months after surgery, or until
the vocal cord function recovered. Vocal cord paresis for
more than 12 months after the operation was regarded as
permanent palsy.
The patients were monitored for postoperative bio-
chemical hypocalcemia at 12, 24, 48, and 72 h postoper-
atively (during hospitalization and after discharge on
morning outpatient visits), with hypocalcemia being
defined as a total serum calcium level lower than
2.0 mmol/L, in either asymptomatic or symptomatic
patients. Persistent hypocalcemia for more than 6 months
after the operation was regarded as permanent
hypoparathyroidism.
Statistical analysis
The sample size was estimated based on the principle of
detecting a 5% difference in the prevalence of recurrent
goiter with a 90% probability at p\ 0.05. The univariate
relation between patient characteristics and the develop-
ment of goiter recurrence and the need for reoperation were
examined. The statistical significance of categorical vari-
ables was evaluated by the v2 test and F test, whereas the
Student’s t-test was used to evaluate continuous variables.
Ten-year recurrence-free survival was calculated using the
Kaplan–Meier method, with the log rank test for compar-
ison between study groups. All the data were entered onto a
dedicated spreadsheet (Microsoft Excel 2010; Microsoft
Corporation, San Jose, CA, USA) by a medical assistant
and then analyzed by a statistician (MedCalc, version 16,
Belgium). p\ 0.05 was considered to indicate
significance.
386 World J Surg (2018) 42:384–392
123
Results
Three thousands one hundred and thirty-three patients were
referred to the Department of Endocrine Surgery, Third
Chair of General Surgery, Jagiellonian University College
of Medicine in Krakow, Poland, for first-time thyroid
surgery between January 2000 and December 2003. Of this
group, 694 patients were eligible for this study, while 94
patients refused to participate. Finally, 600 patients who
signed the informed consent were randomized to three
groups equal in size (n = 200): TT, DO, and BST. Thirty
patients were lost to follow-up at 5 years, leaving 570 who
were followed for at least 60 months: 191 in the TT group,
189 in the DO group, and 190 in the BST group. Further 44
patients were lost to follow-up at 10 years, leaving 526
who were followed for at least 120 months: 177 in the TT
group, 174 in the DO group, and 175 in the BST group
(Fig. 1). Demographic characteristics of patients in this
study are shown in Table 1. In this study, indications for
initial surgery for MNG were: presence of compressive
symptoms in a patient with a thyroid nodule/s of 3 cm or
larger (n = 412), indeterminate result of FNA suggestive
of an increased risk for malignancy (n = 91), discrepancy
between the suspicious ultrasound phenotype of the dom-
inant thyroid lesion/s, and the FNA result suggestive for
non-diagnostic or benign lesion (n = 45), particularly in
cases of a cold thyroid scanning, multiple bilateral thyroid
lesions not responding to TSH suppressive treatment with
l-thyroxine (n = 49), and on patient’s request for cosmetic
indications (n = 3). All indications were equally dis-
tributed between the three study arms.
Primary endpoints
Recurrent goiter was found at 10 years in 1 (0.6%) TT
versus 15 (8.6%) DO versus 39 (22.4%) BST patients
(p\ 0.001 for TT vs. DO or BST and for DO vs. BST),
and revision thyroidectomy was necessary in 1 (0.6%) TT
versus 5 (2.8%) DO versus 14 (8.0%) BST subjects
(p\ 0.001 for TT vs. BST and p = 0.019 for DO vs.
BST). Detailed data are shown in Table 2. Recurrence-free
survival (RFS) for the cohort of 600 patients treated for
multinodular non-toxic goiter by total thyroidectomy (TT),
Fig. 1 Flow diagram of the study
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Table 1 Demographic characteristics of 526 patients who completed the 10-year follow-up
TT
n = 177
DO
n = 174
BST
n = 175
Sex ratioa (M:F) 15:162 18:156 15:160
Mean ageb (years) 45.9 ± 13.9 47.0 ± 15.3 47.9 ± 15.2
Preoperative TSHb (mIU/L) 1.87 ± 0.84 1.82 ± 0.81 1.80 ± 0.91
Preoperative thyroid volume (assessed by ultrasound)a (mL) 75.8 ± 38.4 77.8 ± 39.5 78.8 ± 39.9
TT total thyroidectomy, DO Dunhill operation, BST bilateral subtotal thyroidectomy
a v2 test
b t-test; statistically nonsignificant differences for all values
Table 2 Prevalence of recurrent goiter and need for revision thyroidectomy for 526 patients who completed the 10-year follow-up
TT P
TT versus DO
DO P
DO versus BST
BST P
TT versus BST
Lost to follow-up at 10 years 23 (11.5) 0.296 26 (13.0) 0.329 25 (12.5) 0.343
Recurrent goiter [no (%)] 1 (0.6) <0.001 15 (8.6) <0.001 39 (22.3) <0.001
Need for revision thyroidectomy [no (%)] 1 (0.6) 0.070 5 (2.9) 0.019 14 (8.0) <0.001
Bold values are statistically significant (p\ 0.05)
TT total thyroidectomy, DO Dunhill operation, BST bilateral subtotal thyroidectomy
v2 test for all
Fig. 2 Recurrence free survival
(RFS) for the cohort of 600
patients treated for multinodular
non-toxic goiter by total
thyroidectomy (TT), Dunhill
operation (DO), and bilateral
subtotal thyroidectomy (BST).
TT significantly decreased the
risk of recurrence when
compared to BST: HR 0.795
(0.643–0.982), p\ 0.001 at
10 years (log rank test)
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Dunhill operation (DO), and bilateral subtotal thyroidec-
tomy (BST) is shown in Fig. 2. TT significantly decreased
the risk of recurrence when compared to BST: HR 0.795
(0.643–0.982), p\ 0.001 at 10 years (log rank test).
Secondary endpoints
Cumulative permanent postoperative hypoparathyroidism
after initial surgery and revision thyroidectomy was present
in 1 (0.6%) TT versus 2 (1.1%) DO versus 5 (2.9%) BST
patients (nonsignificant differences), whereas the cumula-
tive permanent recurrent laryngeal nerve injury was found
in 4 (1.1%) TT versus 5 (1.4%) DO versus 5 (1.4%) BST
nerves at risk (nonsignificant differences). Detailed data are
shown in Table 3. The primary outcomes were twice as
inferior at 10 years when compared to 5-year results for
DO and BST, but not for TT [7]. No significant differences
were observed between the three surgeons involved in this
study and the outcomes of surgery they performed.
Discussion
Total thyroidectomy was proposed as the definitive treat-
ment for MNG in order to reduce the risk of goiter recur-
rence to almost zero [11, 12]. The evidence regarding the
balance between the effectiveness and safety of TT com-
pared with more limited thyroid resection modes, such as
DO or BST for MNG, is conflicting and no consensus has
been reached [3, 6, 13].
Table 3 Complications after initial versus revision thyroidectomy and cumulative risk of morbidity among 526 patients who completed the
10-year follow-up
TT P
TT versus DO
DO P
DO versus BST
BST P
TT versus BST
Risk of initial thyroid surgery (n = 600)a
n 200 200 200
Hypoparathyroidism [no (%)]
Total 22 (11.5) 0.007 8 (4.2) 0.241 4 (2.1) <0.001
Transient 21 (11.0) 0.012 8 (4.2) 0.241 4 (2.1) <0.001
Permanent 1 (0.5) 0.316 0 (0) 1.000 0 (0) 0.316
Recurrent laryngeal nerve injury [no (%)]
Total 25 (6.5) 0.352 19 (5.0) 0.088 10 (2.6) 0.009
Temporary 21 (5.5) 0.399 16 (4.2) 0.097 8 (2.1) 0.014
Permanent 4 (1.0) 0.704 3 (0.8) 0.653 2 (0.5) 0.412
Hemorrhage [no (%)] 0 (0) 0.316 1 (0.5) 0.562 2 (1.0) 0.156
Risk of revision thyroidectomy (n = 20)b
n 1 5 14
Hypoparathyroidism [no (%)]
Total 0 (0) 1.000 3 (60.0) 1.000 10 (71.4) 0.333
Transient 0 (0) 1.000 1 (10.0) 1.000 5 (35.7) 1.000
Permanent 0 (0) 1.000 2 (40.0) 1.000 5 (35.7) 1.000
Recurrent laryngeal nerve injury [no (%)]
Total 0 (0) 1.000 3 (60.0) 0.411 5 (17.8) 1.000
Temporary 0 (0) 1.000 1 (20.0) 1.000 2 (7.1) 1.000
Permanent 0 (0) 1.000 2 (40.0) 0.592 3 (10.7) 1.000
Hemorrhage [no (%)] 0 (0) 1.000 0 (0) 1.000 1 (7.1) 1.000
Cumulative risk of initial and revision thyroidectomy (n = 526)a
Permanent hypoparathyroidism [no (%)] 1 (0.6) 0.555 2 (1.1) 0.252 5 (2.9) 0.097
Permanent recurrent laryngeal nerve injury [no (%)] 4 (1.1) 0.717 5 (1.4) 1.000 5 (1.4) 0.724
Hemorrhage [no (%)] 1 (0.6) 1.000 1 (0.6) 0.317 3 (1.7) 0.309
Bold values are statistically significant (p\ 0.05)
TT total thyroidectomy, DO Dunhill operation, BST bilateral subtotal thyroidectomy calculation for nerves at risk, not for patients
a v2 test
b F test
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In the present study, the prevalence of recurrent goiter
and need for future revision thyroidectomy during 10-year
follow-up were significantly reduced after TT as compared
to DO and BST (Table 2). Prevalence of goiter recurrence
tended to increase with time of follow-up (Fig. 2), and
goiter recurrence noted at 5 years (8.2%) was almost
doubled at 10 years (15.5%) following the initial surgery
being more limited than TT (p = 0.002) [7]. In addition,
the need for revision thyroidectomy for goiter recurrence in
procedures more limited than TT was more than sixfold
higher during 10-year follow-up (5.4%) as compared to
values noted during 5-year follow-up (0.8%), whereas it
remained almost abolished following TT (0.6%) during the
entire study period (p\ 0.001) [7].
On the other hand, the risk of temporary, but not per-
manent RLN injury, as well as transient, but not permanent
hypoparathyroidism, was significantly higher following
initial TT as compared to less than total thyroid resections.
However, the risk of initial TT did not overweight the
cumulative risk of postoperative and post-revision perma-
nent morbidity of more limited thyroid resection modes
(Table 3).
Much of the debate regarding the extent of surgical
resection in MNG was inspired by the previously reported
higher prevalence of permanent morbidity following TT
[14–16]. However, more recent data indicate the safety of
TT for benign thyroid disease if surgery is performed by
high-volume surgeons [2, 5, 7, 11, 12, 17–20], which is
also supported by the outcomes of the present study.
Patients after procedures more limited than TT are at an
increased risk of goiter recurrence and need lifelong
surveillance [21]. Subclinical ultrasound-detectable lesions
within the thyroid stumps following subtotal thyroidectomy
are much more frequent than previously thought,
approaching 50% of patients undergoing lifelong follow-up
[21]. Some of these ultrasound findings were even the
reasons for surgical malpractice claims [22]. However,
clinically overt recurrent MNG occurs in up to one-third of
patients with ultrasound-detectable lesions, with a peak
incidence between 10 and 20 years following the initial
procedures more limited than TT [23]. The longer the
follow-up period, the higher the prevalence of recurrent
goiter. Despite the fact that indications for reoperation for
goiter recurrence are rare, the redo surgery may be nec-
essary in approximately 5% of patients following initial
subtotal thyroidectomy [3]. Similar observations were
made in the present study. However, Delbridge et al. [23]
reported much higher values and showed that subtotal
thyroidectomy for MNG resulted in reoperation for recur-
rent disease in up to 20% of patients, reaching a top inci-
dence 13 years following the primary surgery. According
to the 2015 ATA management guidelines, surgery may be
considered for growing nodules that are benign after repeat
FNA if they are large ([ 4 cm), causing compressive or
structural symptoms, or the indications may be based upon
clinical concerns (Recommendation 27 A) [20]. Moreover,
patients with indeterminate nodules who have bilateral
nodular disease, those with significant medical comor-
bidities, or those who prefer to undergo bilateral thy-
roidectomy to avoid the possibility of requiring a future
surgery on the contralateral lobe, may undergo total or
near-total thyroidectomy, assuming completion thyroidec-
tomy would be recommended if the indeterminate nodule
proved malignant following lobectomy (Recommendation
20 B) [20]. In addition, indications for completion thy-
roidectomy can be expected in one-third of patients with
incidentally diagnosed thyroid cancer following BST [3].
As a result, at least one in ten patients following a proce-
dure more limited than TT may require revision thy-
roidectomy in the future. It has been repeatedly shown that
the risk of repeat thyroid surgery is up to 20-fold higher as
compared to the risk of initial TT [3, 4, 23]. Identification
and preservation of vital anatomic structures, such as
recurrent laryngeal nerves and parathyroid glands, may be
compromised during dissection of the scar tissues, leading
to a markedly increased prevalence of permanent morbidity
following thyroid reoperations. In the present study, the
risk of initial TT did not overweight the cumulative risk of
postoperative and post-revision permanent morbidity of
more limited thyroid resection modes. This evidence is in
favor of initial TT for treatment of benign MNG. Never-
theless, recurrent goiter was described even after TT, the
condition that is extremely rare (0.3%), and was usually
caused by an inadequate resection of embryologic remnant
thyroid tissue along the thyrothymic ligament or pyramidal
tract [24]. Hence, thyroidectomy with much attention paid
to identify and remove the entire thyroid gland along its
embryologic descent should effectively eliminate benign
goiter recurrence following TT [24].
The major strength of this study is that it is an RCT with
a long-term follow-up of 10 years that allowed for an
objective estimate of the treatment effects of utilizing
different thyroid resection modes for patients with MNG.
On the other hand, the study protocol has several limita-
tions that should be taken into consideration. First, patients
included into this study were recruited from the southern
part of the Polish territory that historically has been clas-
sified as an iodine-deficient area and endemic goiter area
according to the International Council for Control of Iodine
Deficiency (ICCIDD) criteria. Hence, primary outcomes of
this study may not be universally translated into other
cohorts of patients with MNG, particularly living in iodine-
sufficient areas of the world. However, we believe that in
iodine-deficient areas both iodine prophylaxis and
levothyroxine treatment are needed for efficient long-term
prevention of goiter recurrence following other than total
390 World J Surg (2018) 42:384–392
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thyroidectomy [7]. In addition, all the operations in this
study were performed by high-volume thyroid surgeons
performing more than 200 thyroid operations annually
each. Hence, the prevalence of surgical morbidity reported
in this study cohort may not be achievable for low-volume
thyroid surgeons. Adam et al. [5] reported recently that
81% of all thyroid surgeries in the USA were undertaken
by low-volume surgeons and 51% of surgeons performed
only 1 case per year. Thus, more limited thyroid resections
for benign thyroid disease may still be a safe and effective
alternative for low-volume surgeons, whereas TT should be
reserved for high-volume thyroid surgeons. Last but not
least, the novel surgical adjuncts having a potential for
improving functional outcomes of thyroidectomy, such as
IONM of the laryngeal nerves or near-infrared fluorescence
technique for parathyroid imaging, were not utilized in this
study for initial surgery. However, one can expect that the
rising popularity of these adjuncts in the future can make
safe TT at experienced hands even safer [25, 26].
Encouraging data were recently published by Wojtczak
et al. [27] who found that experience with IONM led to an
increase in RLN identification, a decrease of RLN injury,
and an increase in the safe utilization of TT in non-moni-
tored thyroid operations. Thus, if surgery is chosen as
definitive treatment for MNG and the permanent compli-
cation rate can be kept below 2%, TT should be recom-
mended, as it prevents recurrent nodular goiter and
eliminates the risk of reoperation in the future.
Conclusions
Total thyroidectomy performed by a high-volume thyroid
surgeon can be regarded as the procedure of choice for
patients with MNG, as it entails a significantly lower
prevalence of recurrent goiter and need for revision thy-
roidectomy than other more limited thyroid resections. In
addition, the risk of initial TT does not overweight the
cumulative risk of postoperative and post-revision perma-
nent morbidity of more limited thyroid resection
modalities.
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